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The objective of this research is to design, fabricate and characterize a MEMS-based 
Accelerometer Contact Microphone (ACM) that enables wearable measurement of 
cardiopulmonary mechano-acoustic signals, providing a platform for longitudinal 
monitoring of vital health parameters. This work presents a hermetically-sealed low noise, 
wide bandwidth out-of-plane accelerometer comprising of sub-micron transduction gap 
(270nm) electrodes implemented using HARPSS+ process, which is fabricated and 
characterized as a contact microphone. The sensor is designed using a cantilever topology, 
with a resonant frequency of 13.6kHz and sensitivity of 14.2fF/g. The fabricated sensor is 
interfaced with a commercial capacitance readout circuit, and a low noise performance 
with a noise density of 127µg/√Hz and a bias instability of 22µg is measured. A high 
sensitivity of 76mV/g is recorded by placing the ACM is on a shaker table and applying 1-
g sinusoidal acceleration. The ACM is packaged at atmospheric pressure, reducing its 
operational bandwidth from its measured resonant frequency of 12.5kHz down to 640Hz. 
The use of the ACM in a body-worn auscultation system is validated by mounting it on the 
chest, and non-invasively recording acoustic emissions produced within the thoracic 
cavity. The recorded signals are filtered and processed to extract the phonocardiogram, 
seismocardiogram, lung sounds, and chest wall motion using data processing techniques, 
demonstrating the possibility of accurately capturing multiple types of acoustic and 
vibrational data from the body simultaneously using a single sensor. The efficacy of the 
ACM is further highlighted by its ability to compute vital health parameters such as heart 
rate and heart rate variability with accuracy comparable to a medical-grade ECG system. 
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CHAPTER 1. INTRODUCTION 
1.1 Cardiopulmonary Diseases (CPD) 
Cardiopulmonary diseases (CPD) are the leading cause of mortality globally, and the 
interdependency of cardiac and pulmonary health makes continuous monitoring of 
cardiopulmonary parameters essential for an accurate and timely diagnosis. Patients 
suffering from CPD experience abnormal heart rate and rhythm, chest pain, shortness of 
breath and fatigue. Additionally, chronic coughing and wheezing of lungs is often 
developed as a secondary condition arising due to cardiac dysfunction[1]. There is a 
growing incidence of CPD amongst the aging population globally, leading to high mortality 
rates, increased medical expenses and significant degradation of quality of life of affected 
individuals. Statistics show that cardiovascular diseases account for deaths of over 600,000 
Americans annually, while chronic pulmonary disorders are responsible for over 150,000 
deaths each year. By 2030, about 43% of the population is projected to suffer from some 
form of CPD[2]. 
An effective strategy to improve survival rate is to detect the early onset of CPD and 
slow its progression with preventive care and preemptive treatments[3][4]. This requires 
use of wearable health monitoring platforms for longitudinal monitoring of vital parameters 
leading to accurate diagnosis. Initial physiological markers of developing CPD are 
presence of abnormal heart sounds and adventitious breathing sounds. The use of an 
auscultation device such as a stethoscope is considered as the first step in clinical 




1.2 Auscultation: Basic Diagnostic Practice 
Auscultation is the practice of listening to sounds emanating from a body using tools 
such as a stethoscope. To date, the practice of auscultation has remained unchanged and is 
considered as the basic diagnostic method for health evaluation by doctors around the 
globe. However, the auscultation tool – the stethoscope – has continuously evolved since 
its invention by René Laennec in 1816.  
 
Figure 1 – Evolution of the stethoscope 
The stethoscope offers a cost-effective and accurate method for early detection of 
cardiopulmonary dysfunction. In comparison to electrocardiogram (ECG), the stethoscope 
enables detection of structural abnormalities in the heart valves and defects in the 
cardiopulmonary system that are characterized by adventitious sounds. While imaging 
techniques such as echocardiogram, magnetic resonance imaging (MRI), and computed 
tomography (CT) scan offer high-resolution images of the organs, they require expensive 
equipment and specialized personnel to operate these complex machines. This limits their 
use in a bed-side monitoring environment[6]. 
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There is a growing demand for high performance electronic auscultation devices due 
to their ability to augment traditional clinical equipment for instance, by allowing the 
physicians to remotely diagnose and track patient health post-treatment. Capturing body 
motion coupled with the auscultation data can allow physicians to correlate 
cardiopulmonary sounds to daily activities. Additionally, monitoring the timing of 
abnormal breath sounds with respect to respiratory cycle is of great interest to doctors for 
accurate diagnosis[7].     
Typical electronic stethoscopes use membrane-type microphones which operate by 
generating an electrical response to pressure changes in air caused by sound waves. This 
technique is susceptible to environmental noise and may suffer due to insufficient acoustic 
energy transfer. The piezoelectric-type stethoscope produces electrical signals due to 
distortion of a piezo-crystal coupled to the stethoscope diaphragm.  Again, due to 
distortion, this technique does not accurately capture the sound and resultant output may 
differ from the original tone [6]. Moreover, performance of such microphones is limited 
by their size [8] and are unable to capture low frequency signals such as respiratory rate 
and body motion. 
However, despite the recent advancements in stethoscope design and operation, these 
devices continue to remain bulky and are not suitable for application in a wearable and 
ambulatory setting. This has resulted in the use of stethoscopes being confined to a clinical 
setting, making it imperative to visit a physician for basic auscultatory diagnosis. The short-
term monitoring of cardiopulmonary sounds is inadequate for a comprehensive diagnosis 
as several characteristic acoustic signatures such as pathological ventricular gallops, or 
adventitious breath sounds may not appear under sedentary conditions, making it difficult 
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to accurately identify the disease. Moreover, quantification of auscultation sounds is not 
standardized and is highly dependent on the physician’s experience, making auscultation 
highly susceptible to human error. Hence, to overcome these challenges, we require a 
miniaturized, wearable auscultation tool that can be applied reliably under ambulatory 
conditions for long-term monitoring of these cardiopulmonary sounds. 
1.3 Physiology of the Cardiopulmonary System 
 
Figure 2 – (a) Anatomy of the heart (b) Blood flow in the cardiopulmonary system 
The anatomic structure of the heart is comprised of four chambers: the right atrium, 
the right ventricle, the left atrium, and the left ventricle as shown in Figure 2. Heart valves 
present at the entrance and exit of these chambers regulate the flow of the blood in the 
forward direction while preventing backward regurgitant flow. These valves are composed 
of leaflets, with the tricuspid and semilunar valve consisting of three leaflets each, while 
the mitral valve comprises of two leaflets. The vibration of these cardiac structures results 
in hemodynamic changes and turbulent blood flow, consequently creating vibrational 
waves which travel through the chest wall and can be heard using a stethoscope [9]. The 
turbulent flow is affected by the fluid viscosity, density, velocity, and the diameter of the 
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blood vessels, providing a unique acoustic signature for various cardiovascular 
dysfunction. 
 
Figure 3 – (a) Anatomy of the lungs (b) Types of air flow profile 
The lungs occupy the major volume of the thoracic cavity and are responsible for the 
oxygenation of the blood. Each lung is composed of smaller units called lobes, which are 
separated by Fissures. The right lung consists of three lobes: the superior, middle, and 
inferior lobes. The left lung consists of two lobes: the superior and inferior lobes, as shown 
in Figure 3. The inhaled air accesses the lungs via the trachea. The trachea branches out 
into the bronchi inside the lungs, which further consist of the alveoli at the edges, wherein 
the oxygen-rich air is absorbed by the blood.  
The characteristic features of the air flow are modulated as it passes through these 
pulmonary structures, resulting in production of breath sounds. The two main types of air 
flow seen in the lungs are the laminar and turbulent airflow. Laminar flow occurs when the 
streams of airflow are parallel to the walls and the central streams moves faster than air in 
the peripheral streams, resulting in low frequency, silent vibrations. The turbulent flow 
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occurs in as the air passes through airways with irregular walls, such as the trachea and 
bronchi. The airflow is disorganized and chaotic, producing high frequency audible sounds 
during the respiratory cycle [7]. The outer lining of the lungs and chest wall act as a low-
pass filter, not allowing high frequency sounds to pass through. Therefore, the sound heard 
over the chest wall consists mainly of low frequencies, with harmonics occurring up to a 
few kilohertz signal.  
1.4 Classification of Cardiopulmonary Sounds 
1.4.1 Cardiac Sounds 
The cardiac sounds can be classified into two broad categories: Normal and abnormal 
heart sounds, as shown in the Figure 4. These can be further classified using four 
characteristic features namely – timing, intensity, duration, and frequency. The occurrence 
of the cardiac sounds provides an insight to the functioning of the organ and are closely 
related to the opening and closing of heart valves, along with turbulent blood flow. They 
generally exhibit low characteristic frequencies, in the range of 20-500Hz [10], and are 
best heard at the intercostal spaces, and the apex of the heart. 
The normal heart sounds, comprising of S1 and S2, define systole and diastole period 
and form the basis for analyzing all cardiac auscultations. S1 occurs due to closing of the 
atrioventricular valves (Mitral and Tricuspid), while S2 occurs due to closing of the 




Figure 4 – Classification of Cardiac Sounds 
The first heart sound (S1) occurs as the mitral and tricuspid valves close at the onset 
of ventricular systole and is most prominently heard at the apex and the fourth left 
intercostal space. It exhibits higher amplitude and longer duration amongst all cardiac 
sounds. The S1 sound lasts for a period of 100–200ms, with its frequency components in 
the range of 10-200 Hz. The commonly perceived abnormalities of S1 correspond to its 
intensity – with the sound varying in intensity with every beat. The primary variables 
governing intensity of S1 are strength of ventricular contraction and the position of the 
atrioventricular leaflets at the onset of ventricular systole [10]. 
The second heart sound (S2) occurs at the onset of the ventricular diastole and can be 
clearly heard at the second or third left intercostals space. Its occurrence coincides with the 
completion of the T-wave of the electrocardiogram (ECG). The S2 sound consists of two 
high-frequency components, occurring due to the closure of the aortic valve and the closure 
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of the pulmonary valve. While the intensity of S2 has less diagnostic importance, the 
‘splitting’ of the two high frequency components provides valuable information. In healthy 
subjects, the split between these two components increases by 20-30 milliseconds [10]. 
These characteristic features assist physicians in diagnosing pulmonary hypertension and 
ischemic heart disease.  
The third and fourth heart sounds, also collectively called the gallop sounds, originate 
due to rapid ventricular filling but exhibit different characteristics and clinical significance. 
These sounds occur at low frequencies (20-70 Hz) and are best heard using bell of the 
stethoscope. The third heart sound (S3), occurs in the early diastolic phase and is considered 
pathological in older adults above the age of 40. Presence of these sounds in young people 
is generally physiological. It appears about 120-180ms after the occurrence of the S2 heart 
sound, and provides clinical indications of developing congestive heart failure, and 
valvular regurgitation.   The fourth heart sound (S4) occurs in the late diastolic phase (just 
before S1) and is closely associated with hypertension and fibrosis caused by stiffness of 
the heart tissue.  
Along with the third and fourth heart sounds, presence of other abnormal heart 
sounds such as murmurs and clicks function as biomarkers for developing cardiac 
dysfunction. Characteristic features of these sounds include their location, timing and 
frequency. The sound intensity of these abnormal murmurs during the respiratory cycle 




Figure 5 – Classification of Pulmonary Sounds 
1.4.2 Pulmonary Sounds 
Pulmonary sounds are broadly categorized as normal and adventitious breath sounds, 
as shown in the Figure 5. Patients exhibiting diminished or adventitious breath sounds such 
as crackles, wheezes, and rhonchi, may be diagnosed with conditions such as pneumonia 
and chronic pulmonary disorder. The adventitious respiratory sounds often occur in 
conjunction with the regular breath sounds and require a highly skilled physician for 
differentiating the weak acoustic signatures. 
Normal or tracheal breathing sounds originate in the upper airways in the trachea and 
are produced due to turbulent airflow in the bronchi and trachea. These sounds are 
continuous in nature and range in a frequency range of 100-1500Hz [11]. The characteristic 
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features of such sounds are that they are loud and tubular and nonmusical in nature. These 
can be heard during both – the inhalation and exhalation – phase of respiration. They are 
often used to monitor patients with sleep apnea. 
Vesicular sounds mostly occur during the inspiratory phase and are characterized by 
low frequency (below 100Hz) and low intensity sounds. These generally occur at the 
posterior bases of the lungs, with the inhalation phase sound occurring for longer duration 
compared to the exhalation phase sound [11]. 
Bronchial breathing sounds originate in the central airways in the lobar regions and 
are caused due to turbulent flow vortices along the airways. These sounds continuous in 
nature and range in a frequency range of 600-1000Hz [11]. The characteristic features of 
such sounds are that they are soft and nonmusical in nature. They are often used to monitor 
patients with consolidated lung tissue (e.g. Pneumonia) or fibrosis. 
Crackles are discontinuous adventitious respiratory sounds, occurring in a frequency 
range of 100-2000Hz with a small duration (~20ms). These are commonly heard in patients 
exhibiting obstruction or fluid accumulation in lungs. Wheezes are continuous and musical 
adventitious respiratory sounds occurring for short durations (~80-100ms) in the frequency 
range 100-1000Hz, with certain harmonics present at higher frequencies.  These sounds 
can be monophonic or polyphon and are often used a key indicator of developing asthma 





1.5 Detection of Cardiopulmonary Sounds 
To continuously monitor these mechano-acoustic cardiopulmonary sounds over 
extended periods of time we require wearable sensing systems which are non-invasive, 
simple and cost-effective[12]–[17]. These signals convey physiological parameters that are 
essential for a comprehensive evaluation of the health status of individuals[18], [19]. For 
instance, the opening and closing of the heart valves, along with pumping of blood into the 
arteries and veins, produce acoustic signals in the frequency range of 20-1000 Hz[20], [21]. 
The existence of pathological sounds in these signals can indicate structural defects in the 
heart valves, blockage in arteries or ventricular dysfunctions[22], [23]. In addition, micro-
vibrations of the chest wall in the low frequency range of DC-100 Hz are linked to 
mechanical cardiac events and contain information about valve functionalities and cardiac 
muscle contractility[24], [25]. Moreover, changes in the lung volume during the respiratory 
cycle cause macro-motions of the thorax and abdomen with ultralow frequency below 1 
Hz[26]. This signal is useful to extract the respiratory pattern, which is significant in 
predicting clinical deterioration of patients with chronic airflow obstruction[27], [28], and 
diagnose several other respiratory diseases[29].  
These mechano-acoustic signals comprise a wide range of intensities and 
frequencies; requiring, ultrasensitive sensors with high dynamic range and wide bandwidth 
to record these signals with high fidelity. In addition, these sensors must be small and 
lightweight to be easily accommodated in a wearable platform. This enables continuous 
monitoring of cardiopulmonary system over extended period of time and facilitates early 
detection and comprehensive diagnosis[14]–[16], [30]. Existing systems including digital 
stethoscopes and accelerometers are not well-suited for low-profile, wearable and high-
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precision monitoring systems. Digital stethoscopes rely on large size membranes to acquire 
weak acoustic signals emanating from the body. Miniature accelerometers with low-
bandwidth have been used in limited capacity to obtain mechanical vibrations and record 
SCG signals and respiratory patterns[31], [32] but fail to detect characteristic acoustic 
signatures of ventricular dysfunction such as pathological S3 heart sounds occurring in 
patients with congestive heart failure, and adventitious pulmonary sounds associated with 
deteriorating cardiopulmonary conditions[7], [19], [23]. While preliminary studies using 
accelerometers in implantable defibrillators has been reported for monitoring cardio-
mechanical signals in heart failure patients[33], these devices are unsuitable for preventive 
care as they require expensive and complex surgical procedures for implantation.  
An effective approach to tackle these challenges is using a capacitive accelerometer 
contact microphone (ACM). A micro-g accelerometer with large bandwidth (fres >10 kHz) 
and low noise (<10 µg√Hz) out-of-plane sensitivity functions as a contact microphone. By 
having a high resonant frequency, the accelerometer can pick up µg-level accelerations 
produced by acoustically vibrating structures. Such a microphone is not sensitive to air-
borne acoustic emissions, but only sensitive to vibrations from its contact surface. Its small 
size allows it to replace bulky stethoscopes with ergonomic wearable auscultation systems 
that can precisely measure cardiopulmonary sounds, chest wall motion, seismocardiogram 
(SCG) signal as well as body motion of an individual simultaneously.  
In this work, a low noise, wide bandwidth out-of-plane accelerometer with nano-gap 
(270nm) capacitive electrodes implemented using HARPSS+ process [34], [35] is 
designed, fabricated and characterized as a contact microphone. The performance of this 
accelerometer contact microphone is characterized using a shaker table, and the use of this 
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contact microphone as a body-worn auscultation device is validated by mounting it on the 
chest and recording sounds produced in the thoracic cavity. The recorded signals are 
filtered and processed to extract the heart sounds and SCG signal from the recorded data. 
Similarly, lung sound and chest wall motion are extracted using data processing techniques, 
demonstrating the possibility of accurately capturing multiple types of acoustic and 






CHAPTER 2. ACCELEROMETER CONTACT MICROPHONE 
2.1 General Operation Principle  
An accelerometer contact microphone (ACM) is micro-sensor that unifies the 
functionality of an inertial device – an accelerometer – used for measuring activity and 
body motion, with an auscultatory sensor such as a microphone for capturing heart and 
lung sounds, into a single-chip device. The sensor exhibits an extremely high sensitivity in 
the out-of-plane direction, with a wide operational bandwidth, more than 10kHz, along 
with an ultra-low noise performance, having a noise density lower than 10 µg√Hz. 
The general operation principle of the ACM can be described using a simplified 
lumped model, as shown in Figure 6, comprising of a proof mass M suspended in an 
accelerating reference frame via a mechanical spring K and damper D. Upon externally 
applied acceleration, the proof mass experiences a displacement X, which can be modeled 
using Newton’s second law of motion, given by equation (1). 
 









































Since the motion of the proof mass is a second order equation, the operational 
bandwidth is determined by the fundamental resonant frequency ω0. To capture all acoustic 
vibrations, the ACM requires to have an operational bandwidth of at least 10 kHz. 
However, at such high resonant frequencies, the displacement of the proof-mass reduces 
significantly, to the order of nanometers. Detection of such small displacements using 
capacitive transduction is extremely challenging due to substantial degradation of the 
signal-to-noise ratio. Hence to overcome this challenge, the capacitive transduction gap 
size is scaled to sub-micron levels (~300nm), effectively increasing the ratio between 
displacement and capacitive transduction gap, to achieve a higher signal strength. 
The operational bandwidth of the ACM is also dependent on the damping coefficient 
of the device, which is given by equation (4). The damping coefficient of the quasi-static 
capacitive accelerometer is primarily dictated by the squeezed-film-damping, occurring 
due to the interaction between the compressed air-molecules and the microstructure, and is 
given by equation (5). Here Ne represents the number of electrodes, ηeff is the viscosity of 
the ambient gas, le is the electrode length, he is the electrode thickness, and d is the 




Bandwidth = 𝜔𝜔0�1 − 2𝜁𝜁2 + �2 − 4𝜁𝜁2 + 4𝜁𝜁4 (4) 
 








Figure 7 – (a) Operational bandwidth requirement of the ACM with a minimum 
resonant frequency of 10kHz to accurately capture the acoustic vibrations. (b) 
Critically damped operation of the ACM (Q=0.7) to ensure maximum operational 
bandwidth. 
Since the squeeze-film damping is subject to the capacitive gap, by scaling down 
these gap sizes to sub-micron levels along with hermetically sealing the ACM in a low 
vacuum environment, we can precisely control the damping coefficient and achieve a 
critically-damped device with maximum operational bandwidth.  
To capture all acoustic vibrations with high fidelity, the ACM must also have a low 
noise performance (<10 µg/√Hz) along with the wide bandwidth (>10kHz). Utilizing the 
nanoscale capacitive transduction gaps in ACM, we can overcome design challenges 
pertaining to tradeoffs between the operational bandwidth and noise performance 
experienced in conventional accelerometer design. The total noise of the ACM is given by 
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a combination of the mechanical and electrical components, namely the Brownian Noise 
Equivalent Acceleration (BNEA) and Circuit Noise Equivalent Acceleration (CNEA). 
These noise components can be analytically expressed as a function of the resonant 












As per the equations of the BNEA and CNEA, the noise performance of the device 
scales proportionally to the resonant frequency and the transduction gap size. The increased 
noise level due to the desired wide operational bandwidth, is compensated by scaled-down 
sub-micron transduction gaps, enabling implementation of high-performance ACM 
devices with a small footprint, high sensitivity and wide operational bandwidth [36], [37].   
2.2 ACM Sensor Design 
An out-of-plane torsional cantilever topology [38] is chosen to implement the ACM, 
wherein the proof mass is supported by torsional tethers at one end, while the other end is 
free to rotate. To maintain a small form factor, the sense electrodes are placed within the 
proof mass area, and a differential top electrode configuration is employed to suppress 
common mode noises, as shown in Figure 8. This differential capacitance measurement is 
achieved by designing the sense electrodes such that the top poly-silicon is connected to 
the ‘-’ sense electrode and overhangs the proof-mass to create the first transduction 
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capacitance, while at the ‘+’ sense electrode the transduction capacitance is created with 
the top poly-silicon connected to the proof-mass and overhanging the sense electrode area. 
When acceleration occurring due to acoustic vibrations is applied orthogonal to the device, 
generated torque will rotate the proof-mass, changing the capacitance between sense 
electrodes and proof-mass, as shown in Figure 9. 
 
Figure 8 – COMSOL simulation of ACM device structure. The proof mass is 
supported by support tethers at one end and houses the ‘+’ and ‘-’ sense electrode 
within its footprint. Top polysilicon is used to create differential sensing topology. 
The dimensions of the proof-mass are determined such that the mechanical noise of 
the ACM is minimized, and the length of the device remains much greater than the width 
to maximize the restoring force. Use of such a design topology ensures low stiction and 
high yield from the fabrication process. The resonant frequency exceeding 10kHz which is 
required by the ACM is achieved by fine-tuning the dimensions of the support tethers. 
Additionally, the placement of the tethers is done such that subsequent resonant modes 
occur at significantly higher frequencies. The operational resonant frequency of the ACM 
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is 13.6 kHz, with the successive resonant modes occurring at 82.6 kHz and 82.9 kHz, 
respectively. The simulated modes shapes of the device are shown in Figure 10.  
 
Figure 9 – Schematic implementation of differential sensing topology using top-
polysilicon electrodes and a 270nm transduction. Proof-mass moves perpendicular to 
the plane of the device. 
 
Figure 10 – Simulated resonant mode shapes of the ACM. The fundamental mode 
shape is the primary mode of operation wherein the device acts as a cantilever and 




Both the sense electrodes of the ACM are designed identically to maintain the center 
of mass of the device and minimize any process variations. They have sufficient 
transduction area to have equal capacitances of 1.7pF at each electrode to achieve a high 
scale factor. The ‘-’ sense electrode is constructed with the polysilicon layer attached to the 
movable proof-mass and overhanging the fixed sensing electrode. On the other hand, the 
‘+’ sense electrode is constructed with the polysilicon attached to the fixed sense electrode 
and overhanging the moveable proof-mass. Hence, as the proof-mass displaces along the 
z-axis, the capacitance on each electrode changes as the transduction gap size increases or 
decrease, resulting in a differential readout of capacitance. The change in capacitance is 
characterized by increasing the bias voltage across the electrode. At an input bias voltage 
of 1V, the change in capacitance at each ACM electrode is 40.2fF, as shown in Figure 11.  
The overall scale factor for the ACM is obtained by combining the total change in 
capacitance for 1-g applied acceleration. The simulated scale factor for this device is 
14.2fF/g, with the applied acceleration up to 16-g, as shown in Figure 12. The cross-axis 




Figure 11 – Change in capacitance with increasing applied bias voltage across each 
sensing electrode. 
Since the operational bandwidth of the ACM is dependent on the resonant frequency, 
damping coefficient and packaging pressure level, a finite-element simulation is conducted 
to accurately identify these parameters. For maximum bandwidth, the device must operate 
in a critically damped condition with a damping coefficient of 0.707. Varying the pressure 
from low vacuum conditions of 10 Torr pressure to an atmospheric pressure of 760 Torr 
changes the operational bandwidth as shown in Figure 13. At atmospheric pressure, the 
operational bandwidth is reduced to 640Hz, while at low vacuum pressure an underdamped 




Figure 12 – Simulated scale factor of the ACM device. The device has a sensitivity of 
14.2fF/g in the out0-of-plane direction, with a cross-axis sensitivity of <0.1% along 
both orthogonal axes. 
 
Figure 13 – Simulated operational bandwidth of the ACM at varying pressure levels. 
The device operates in an overdamped condition at atmospheric pressure (760 Torr) 




The device is fabricated using the HARPSS+ process on an SOI (Silicon-on-
Insulator) wafer having 40µm thick device layer with ~270nm capacitive gaps [34], [35]. 
After the releasing process, the completed wafer is then wafer-level packaged using 
eutectic bonding to a silicon capping wafer with built-in through-silicon-vias (TSV). Figure 
14 shows the SEM of the uncapped ACM device and the device cross section with a 270nm 
transduction gap. 
 
Figure 14 – (a)SEM photograph of the fabricated ACM device showing the proof-
mass and sensing electrodes. (b) Cross-sectional image of the sensing electrode 
displaying the thin top-poly electrode overhanging the single-crystal silicon (SCS) 
sense electrode in the device layer. (c) close-up view of the cross-sectional image 
demonstrating the 270nm transduction gap.    
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CHAPTER 3. SENSOR CHARACTERIZATION  
3.1 Evaluation Board Development 
The fabricated ACM microsensor is interfaced with MS3110P – a commercially 
available off-the-shelf capacitance readout circuit – that exhibits low capacitive resolution 
(4aF/√Hz) along with a wide bandwidth (programmable up to 8kHz). A miniature 
evaluation board is developed by utilizing both sides of a 4-layered circuit board to ensure 
a small factor, which is essential to eliminate any undesired resonant frequency arising due 
to the circuit board during tests under high frequency vibrations. The differential electrode 
pair of the MEMS device are wire-bonded to the CS1IN and CS2IN pins of the circuit, 
while the CSCOM pin is connected to the device layer. The handle layer of the MEMS 
device is connected to ground.  
 
Figure 15 – Schematic of miniature evaluation board designed for test and 
characterization of the ACM.   
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The top-side of the evaluation board, housing the wire-bonded wafer-level-packaged 
MEMS devices, is covered in a thin layer of clear epoxy potting compound DP270 
(manufactured by 3M) as shown in Figure 16. The 2-part epoxy (consisting of the base and 
accelerator) is mixed in a ratio 1:1 by volume and cured at room temperature for 24 hours. 
This epoxy layer protects the bonding wires from damage against handling and allows the 
MEMS sensor to be placed directly over the testing surface, thus achieving good 
vibrational coupling. Additionally, the epoxy protects the device from detrimental 
environmental effects such as moisture.    
 
Figure 16 – (a) Fabricated and assembled ACM evaluation board on a miniature PCB 
(2cm x 2cm) with the MEMS die placed on top-side and the interface electronics on 
the bottom-side of the PCB. (b) Cross-sectional schematic diagram of the PCB 
demonstrating the location of all components. A protective epoxy layer is placed on 
top of the MEMS die.  
3.2 Environment Setup and Testing 
Characterization of the fabricated ACM device is carried out by performing a series 
of tests with respect the sensitivity, dynamic range, bandwidth, and noise performance. The 
measured data is then compared to the simulation results to validate the design.  
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The evaluation board – comprising of the MEMS and MS3110P – provides an analog 
output voltage proportional to the applied acceleration, which is determined by the 
capacitance-voltage (C-V) gain setting of the readout circuit. The programmability of the 
readout circuit allows the user to choose the desired gain setting by varying the feedback 
capacitance. A C-V gain setting of 4.28mV/fF was set for all characterization results. A 
high precision 16-bit data acquisition unit (NI-9220 by National Instruments) is used to 
record the output voltage.  
3.2.1 C-V Measurement Test 
Prior to interfacing the ACM to the readout circuit, it is essential to determine the 
functionality of the MEMS device. This is accomplished by measuring the capacitance 
across the electrodes and the proof mass of the accelerometer using an LCR meter. The 
measured nominal capacitance value is compared to the simulated capacitance value, while 
considering the effect of the capping wafer along with parasitic capacitances that may arise 
due to the circuit board. Then, a bias voltage is applied to simulate an external acceleration 
and the changes in the capacitance values are noted. Figure 17 demonstrates the change in 
capacitance as the bias voltage increases from 0 to 1 V. A nominal capacitance of 3.3pF on 




Figure 17 – Capacitance-Voltage measurements demonstrating the change in 
capacitance as we increase the bias voltage between the proof-mass and sense 
electrodes. Measurements done using an LCR meter.  
3.2.2 Sensitivity Test 
To measure the sensitivity (SZ), a shaker table (ET-126 HF by Lab Works Inc.) is 
used to apply a precise 1-g sinusoidal acceleration perpendicular to the plane of the device, 
and a peak voltage of 72.6mV/g is observed as shown in Figure 18. Additionally, the 
applied acceleration levels are increased up to 16-g to demonstrate the wide dynamic range 
of the sensor. To measure the cross-axis sensitivity (SXZ, SYZ), the evaluation board is then 
placed perpendicular to the shaker table. The measured cross-axis sensitivity is less than 
3%, which arises mainly due to the misalignments occurring during placement of the 




Figure 18 – (a) Placement of an ACM evaluation board on the ET-126HF shaker 
table. A sinusoidal acceleration signal of 1g at 30Hz frequency is applied. 
Corresponding output waveform is plotted using an oscilloscope, demonstrating a 
sensitivity of 72.6mV/g. (b) Accelerations up to 16g are applied using the shaker table 
and output voltages are recorded, demonstrating a high dynamic range of the ACM. 
3.2.3 Noise Performance 
The noise performance of the sensor is characterized by placing it in under 0-g 
acceleration along its primary axis and recording the output for a long duration. The output 
voltage is used to plot the Allan Deviation Plot (as shown in Figure 19), demonstrating a 
low noise performance of 127µg/√Hz and a bias instability of 22µg. However, the system 
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is limited by the capacitive resolution of the interface circuit, and the noise performance 
can be further improved by utilizing a custom-made ASIC for optimal operation of the 
designed MEMS device. 
 
Figure 19 – Allan deviation plot demonstrating the low noise performance of the 
ACM, showing a velocity random walk of 127µg/√Hz and a bias instability of 22µg.  
3.2.4 Resonant Frequency and Operational Bandwidth 
Since the ACM is a second-order system, its operational bandwidth is determined by 
resonant frequency of the device. The resonant frequency is measured by placing the device 
in a vacuum chamber and using a network analyzer to detect the resonant peak. The 
measured resonant frequency is 12.5 kHz, as shown in Figure 20. However, since the 
device operates at atmospheric pressure, the operational bandwidth is attenuated. This is 
measured by placing the evaluation board on the shaker table and recording the output 
voltage at varied input acceleration frequencies. Figure 20 shows the transfer function of 














VRW = 127 µgHz-1/2
BI = 22 µg
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the device with an operational bandwidth of 640 Hz, which is in good agreement with the 
simulated operational bandwidth. 
 
Figure 20 – (a) The operational bandwidth of 640Hz of the ACM measured by 
sweeping the input acceleration frequency using a shaker table. (b) The resonant peak 
at 12.5kHz indicating the high operational bandwidth that can be achieved with 
vacuum packaging using this device.  
Table 1 – Performance Summary of the ACM  
Parameter Value 
Sensitivity 76 mV/g 
Resonant frequency 12.5 kHz 
Operational Bandwidth 640 Hz 
Linear dynamic range 160 m/s2 (16 g) 
Die size 2 mm×2 mm×1 mm 
Gap size 270 nm 
Measured Noise density 127 µg/√Hz (@ 1 Hz) 
Brownian Noise of MEMS 3.6 µg/√Hz (@10 Torr Pressure) 
Measured Cross axis sensitivity <3% 
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CHAPTER 4. BODY-WORN AUSCULTATION DEVICES 
4.1 Sensor Placement 
Several auscultation locations for cardiopulmonary sounds are available in the 
intercostal spaces (ICS) (i.e. the space between two consecutive ribs) on the chest. 
Cardiopulmonary sounds, which lie between 20 to 2500 Hz frequency range[39], are 
recorded by mounting the sensor left of the sternum in the 5th intercostal space, shown in 
Figure 21. The PCB is held in place using a chest strap to provide firm contact between the 
board and skin. Such configuration is essential to pick-up high-fidelity audio signals. 
 
Figure 21 – Sensor locations for placement of the ACM for auscultation applications.   
4.2 Cardiopulmonary Sound Sensing 
The senor board is interfaced with NI-9220 DAQ to collect the data and a 
MATLAB program is used to filter the recorded signals which can be further stored in 
audio file format for playback. Unlike piezoelectric microphones, the ACM can measure 
accelerations down to DC level. This attribute is used to obtain additional information such 
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as body motion, heart rate, respiratory rate and even SCG signal. Moreover, using an array 
of the ACMs can result in high-precision activity detection of the user, thus providing an 
additional layer of information for correlation of auscultation to daily activities. The higher 
frequency components (> 20Hz) of the recorded signal correspond to the cardiopulmonary 
sounds. 
 
Figure 22 – Signal processing and filtering algorithm used in extraction of useful 
information from the recorded ACM signal output.  
The filtering algorithm shown in Figure 22 is used to separate the low frequency 
component of chest wall motion and the high frequency component of the sound signal. 
The filtering is performed using high-order Butterworth filters on the basic criteria of 
audible (> 20Hz) and inaudible frequencies (< 20Hz). A wavelet denoising technique is 
used on the high frequency components to reduce noise and extract signal features[40]. 
The resultant waveforms are shown in Figure 23 and 24, corresponding to extracted 
cardiopulmonary signals. 
There are two major cardiac sounds; S1 and S2, which occur due to closing of the 
atrioventricular valves (Mitral and Tricuspid) and closing of the semilunar valves (Aortic 
and Pulmonary), respectively. The period from S1 to S2 is known as Systole, whereas the 
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S2 to S1 period is known as Diastole [41], as shown in Figure 23. The recorded signal, 
known as phonocardiogram (PCG), is characterized by a ‘lub-dub’ sound, and provides a 
solid foundation for preliminary diagnosis, based on the frequency content and amplitude 
of the signal, of any cardiac disease. 
 
Figure 23 – Recorded phonocardiogram signals of the heart demonstrating the two 
major heart sounds.  
Another feature captured along with the heart sounds is the SCG signal, defined as 
the micro-movements of the chest due to the pumping of blood at every heartbeat[24]. As 
this signal lies in the frequency range of 0-20Hz, it is typically captured using a precision 
micro-g accelerometer. The dual nature of the proposed contact microphone enables the 
detection of the SCG signal, while measuring cardiac sounds, as shown in Figure 24. The 
importance of capturing this waveform is marked by its unobtrusive nature and ability to 
detect early onset of several diseases such as acute myocardial disease, asymptotic 




Figure 24 – Recorded seismocardiogram (SCG) signal demonstrating the peaks 
corresponding to the opening and closing of the heart valves with each heartbeat. 
Auscultation of the lungs provides vital information regarding their physiology 
such as obstructions in airway or presence of liquid in the organ. The qualities of breath 
sounds modify as air passes through the lungs. The pitch and duration of recorded lung 
sounds differ with respect to location of the senor. The presence of adventitious breath 
sounds such as crackles or wheezes usually indicate disease[19]. To accurately identify the 
timing of abnormal breath sounds within a respiratory cycle, the inspiration and expiration 
can be monitored by tracking the movement of the chest wall. Normal “vesicular” breath 
sound recorded by our accelerometer contact microphone is shown in Figure 25 and 26. 
The ACM demonstrates high-fidelity cardiopulmonary auscultation sensing 
capability as well as high sensitivity towards motion artifacts. Characteristic features of 





Figure 25 – Low frequency chest wall motion showing the breathing pattern of an 
individual. Respiratory rate is calculated using this waveform.  
 
Figure 26 – High frequency ‘vesicular’ lung sounds from a healthy subject. The 
sounds can be categorized based on their inhalation and exhalation phase within the 
respiratory cycle.   
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4.3 Computed Health Parameters using the ACM 
The sensor is applied to compute diagnostic parameters such as heart rate variability 
(HRV) and inter-beat intervals (IBIs) by extracting the time intervals based on the 
vibrational signatures of cardiac activities. Figure 27 displays the simultaneously recorded 
time domain signals of a medical-grade ECG alongside the ACM. Analogous to the R-peak 
of the ECG signal, the opening of the aortic valve is used as a reference peak to segment 
the recorded signal into individual beat components. 
 
Figure 27 – (a) Time domain plot of measured ECG signal alongside the ACM. (b) 
Correlation plot illustrating linear curve fit with r2 = 0.98 confirming effective use of 
ACM for computation of diagnostic parameters (c) Bland-Altman plot comparing the 
technologies demonstrates 95% confidence interval having a range of 0.01s  
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The IBIs calculated using the two methods demonstrates a high correlation, 
indicating a linear fit with r2=0.98. A Bland-Altman plot quantifies this similarity showing 
the 95% confidence interval having a range of 0.01s. This signifies the use of the ACM for 
vital parameter monitoring in place of ECG electrodes without compromising on signal 






CHAPTER 5. CONCLUSION 
The growing demand for remote health monitoring and wearable technologies will 
necessitate the integration of sensors into smaller form-factor with increased functionality 
and precision performance. The presented accelerometer contact microphone, whose 
functionality and feasibility are validated by an on-body auscultation test to capture heart 
and lung sounds, along with simultaneous recording of SCG signals and chest wall 
motions, represents as a major step towards this goal. The ability to compute vital health 
parameters such as the heart rate and heart rate variability within a high confidence interval 
as compared to medical-grade ECG further supports the use of the ACM in wearable 
auscultation devices. By integrating the functionality of a microphone and an 
accelerometer in a single MEMS device, the cost of manufacturing wearable devices can 
be reduced significantly.  
The functionality of the ACM can be further improved by optimizing the device 
design to achieve a higher sensitivity, along with packaging the ACM under low vacuum 
conditions for an extended operational bandwidth exceeding 10kHz. Development of a 
noise matched ASIC will enable a lower noise performance of the sensor, allowing 
detection of weak pathological mechano-acoustic signatures from the body. Integrated 
packaging of the ACM sensor and ASIC will facilitate a miniaturized footprint and allow 
mechano-acoustic monitoring of several body parts, including knee joint sounds and 
abdominal bruits. Additional degrees of freedom of motion sensing can be added to the 
same die, e.g. a tri-axial wide-bandwidth micro-g accelerometer can be implemented using 
the same process platform technology, enabling motion capture along all orthogonal. 
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Implementation of classification and machine learning algorithms can simplify the data 
processing and provide objective quantification to cardiac health parameters which is 
currently unfeasible using conventional or electronic stethoscopes. Development of a 
wireless data acquisition system around the ACM will further increase the usability of the 
device during ambulatory conditions,  such as during a stress test, allowing physicians to 
closely monitor the changes in the mechano-acoustic vibrations as the body undergoes 
physical activity. Using this device, a physician can observe cardiopulmonary health 
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